Flow Cytometric Intracellular 5-Methyl Cytosine Expression and Its Correlation With Cytogenetics and Measurable Residual Disease in Adult B-Lineage Acute Lymphoblastic Leukemia

被引:0
作者
Sreedharanunni, Sreejesh [1 ]
Kaur, Prabhjot [1 ]
Raina, Sudhanshi [1 ]
Bose, Parveen [1 ]
Kumar, Arun [1 ]
Sharma, Praveen [1 ]
Naseem, Shano [1 ]
Jain, Arihant [2 ]
Khadwal, Alka [2 ]
Sachdeva, Man Updesh Singh [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
关键词
5-methyl cytosine; flow-cytometry; fluorescence in situ hybridization; measurable residual disease; Ph-positive ALL; DNA METHYLATION;
D O I
10.1111/ijlh.14412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:349 / 353
页数:5
相关论文
共 30 条
  • [21] B-lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting
    Mikhailova, Ekaterina
    Itov, Albert
    Zerkalenkova, Elena
    Roumiantseva, Julia
    Olshanskaya, Yulia
    Karachunskiy, Alexander
    Novichkova, Galina
    Maschan, Michael
    Popov, Alexander
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2022, 102 (05) : 353 - 359
  • [22] Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year
    van der Linde, Riana
    Gatt, Prudence N.
    Smith, Sandy
    Fernandez, Marian A.
    Vaughan, Lachlin
    Blyth, Emily
    Curnow, Jennifer
    Brown, David A.
    Tegg, Elizabeth
    Sasson, Sarah C.
    CANCERS, 2023, 15 (20)
  • [23] Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
    Popov, Alexander
    Henze, Guenter
    Roumiantseva, Julia
    Budanov, Oleg
    Verzhbitskaya, Tatiana
    Boyakova, Elena
    Tsaur, Grigory
    Fadeeva, Maria
    Lagoyko, Svetlana
    Zharikova, Liudmila
    Miakova, Natalia
    Litvinov, Dmitry
    Khlebnikova, Olga
    Streneva, Olga
    Ponomareva, Natalia
    Novichkova, Galina
    Fechina, Larisa
    Karachunskiy, Alexander
    LEUKEMIA RESEARCH, 2023, 125
  • [24] Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol
    Popov, Alexander
    Henze, Guenter
    Tsaur, Grigory
    Budanov, Oleg
    Roumiantseva, Julia
    Belevtsev, Mikhail
    Verzhbitskaya, Tatiana
    Movchan, Liudmila
    Lagoyko, Svetlana
    Zharikova, Liudmila
    Olshanskaya, Yulia
    Riger, Tatiana
    Valochnik, Alena
    Miakova, Natalia
    Litvinov, Dmitry
    Khlebnikova, Olga
    Streneva, Olga
    Stolyarova, Elena
    Ponomareva, Natalia
    Novichkova, Galina
    Aleinikova, Olga
    Fechina, Larisa
    Karachunskiy, Alexander
    CANCER MEDICINE, 2024, 13 (08):
  • [25] Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia
    Yana, Nan
    Wang, Zi-Long
    Wang, Xiao-Juan
    Gale, Robert Peter
    Zhou, Ya-Lan
    Zhao, Ming-Yue
    Wu, Li-Xin
    Liao, Ming-Yue
    Yang, Jie
    Wang, Chun-Yang
    Zhu, Jian-Hua
    Jiang, Hao
    Jiang, Qian
    Liu, Yan-Rong
    Chang, Ying-Jun
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Ma, Tong-Hui
    Huang, Xiao-Jun
    Ruan, Guo-Rui
    CANCER LETTERS, 2024, 598
  • [26] Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting
    Irving, Julie
    Jesson, Jenny
    Virgo, Paul
    Case, Marian
    Minto, Lynne
    Eyre, Lisa
    Noel, Nigel
    Johansson, Ulrika
    Macey, Marion
    Knotts, Linda
    Helliwell, Margaret
    Davies, Paul
    Whitby, Liam
    Barnett, David
    Hancock, Jeremy
    Goulden, Nick
    Lawson, Sarah
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (06): : 870 - 874
  • [27] Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapy
    Nedumannil, Rithin
    Ritchie, David
    Bajel, Ashish
    Ng, Ashley P.
    Harrison, Simon J.
    Westerman, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (02) : 168 - 176
  • [28] A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement
    Popov, Alexander
    Henze, Guenter
    Roumiantseva, Julia
    Budanov, Oleg
    Belevtsev, Mikhail
    Verzhbitskaya, Tatiana
    Boyakova, Elena
    Movchan, Liudmila
    Tsaur, Grigory
    Fadeeva, Maria
    Lagoyko, Svetlana
    Zharikova, Liudmila
    Miakova, Natalia
    Litvinov, Dmitry
    Khlebnikova, Olga
    Streneva, Olga
    Stolyarova, Elena
    Ponomareva, Natalia
    Novichkova, Galina
    Fechina, Larisa
    Aleinikova, Olga
    Karachunskiy, Alexander
    PEDIATRIC BLOOD & CANCER, 2023, 70 (06)
  • [29] Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
    Mikhailova, Ekaterina
    Illarionova, Olga
    Komkov, Alexander
    Zerkalenkova, Elena
    Mamedov, Ilgar
    Shelikhova, Larisa
    Olshanskaya, Yulia
    Miakova, Natalia
    Novichkova, Galina
    Karachunskiy, Alexander
    Maschan, Michael
    Popov, Alexander
    CANCERS, 2022, 14 (21)
  • [30] Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker
    Abaza, Hala M.
    Alfeky, Mervat A. A.
    Eissa, Deena S.
    Fattah, Mona F. Abdel
    Annaka, Laila M.
    Ebeid, Fatma S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 200 - 207